[PETDAG] QoQ Quarter Result on 30-Sep-2015 [#3]

Stock
[PETDAG] PETRONAS DAGANGAN BHD
Announcement Date
02-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Sep-2015 [#3]
Profit Trend
QoQ- -19.88%
YoY- 36.46%
Quarter Report
Latest QR
Upcoming QR
PETDAG's Result
PETDAG's Financial Summary
View:
Show?
Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 5,331,453 4,910,471 6,047,568 6,529,317 6,465,341 6,101,188 7,452,818 -20.02%
PBT 249,663 295,642 129,145 297,679 376,102 283,797 11,739 669.05%
Tax -34,220 -74,666 -36,826 -77,362 -101,643 -76,268 -11,114 111.78%
NP 215,443 220,976 92,319 220,317 274,459 207,529 625 4833.79%
-
NP to SH 214,953 219,402 92,113 218,884 273,210 205,768 445 6079.56%
-
Tax Rate 13.71% 25.26% 28.52% 25.99% 27.03% 26.87% 94.68% -
Total Cost 5,116,010 4,689,495 5,955,249 6,309,000 6,190,882 5,893,659 7,452,193 -22.19%
-
Net Worth 5,056,681 4,957,335 4,947,400 4,997,073 4,897,728 4,748,710 4,748,710 4.28%
Dividend
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Div 139,083 119,214 198,690 139,083 139,083 119,214 218,559 -26.03%
Div Payout % 64.70% 54.34% 215.70% 63.54% 50.91% 57.94% 49,114.58% -
Equity
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Net Worth 5,056,681 4,957,335 4,947,400 4,997,073 4,897,728 4,748,710 4,748,710 4.28%
NOSH 993,454 993,454 993,454 993,454 993,454 993,454 993,454 0.00%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin 4.04% 4.50% 1.53% 3.37% 4.25% 3.40% 0.01% -
ROE 4.25% 4.43% 1.86% 4.38% 5.58% 4.33% 0.01% -
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 536.66 494.28 608.74 657.23 650.79 614.14 750.19 -20.02%
EPS 21.60 22.10 9.30 22.00 27.50 20.70 0.04 6556.72%
DPS 14.00 12.00 20.00 14.00 14.00 12.00 22.00 -26.03%
NAPS 5.09 4.99 4.98 5.03 4.93 4.78 4.78 4.28%
Adjusted Per Share Value based on latest NOSH - 993,454
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 536.66 494.28 608.74 657.23 650.79 614.14 750.19 -20.02%
EPS 21.60 22.10 9.30 22.00 27.50 20.70 0.04 6556.72%
DPS 14.00 12.00 20.00 14.00 14.00 12.00 22.00 -26.03%
NAPS 5.09 4.99 4.98 5.03 4.93 4.78 4.78 4.28%
Price Multiplier on Financial Quarter End Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 -
Price 23.40 24.10 24.86 21.82 20.58 20.00 17.12 -
P/RPS 4.36 4.88 4.08 3.32 3.16 3.26 2.28 54.12%
P/EPS 108.15 109.12 268.12 99.03 74.83 96.56 38,220.07 -98.00%
EY 0.92 0.92 0.37 1.01 1.34 1.04 0.00 -
DY 0.60 0.50 0.80 0.64 0.68 0.60 1.29 -39.99%
P/NAPS 4.60 4.83 4.99 4.34 4.17 4.18 3.58 18.20%
Price Multiplier on Announcement Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 15/08/16 11/05/16 19/02/16 02/11/15 06/08/15 11/05/15 12/02/15 -
Price 23.48 22.70 25.40 22.50 21.44 21.64 17.00 -
P/RPS 4.38 4.59 4.17 3.42 3.29 3.52 2.27 55.05%
P/EPS 108.52 102.79 273.94 102.12 77.96 104.48 37,952.18 -97.99%
EY 0.92 0.97 0.37 0.98 1.28 0.96 0.00 -
DY 0.60 0.53 0.79 0.62 0.65 0.55 1.29 -39.99%
P/NAPS 4.61 4.55 5.10 4.47 4.35 4.53 3.56 18.82%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment